CoChat

Tight junction proteins expression and modulation in immune cells and multiple sclerosis

Open access
Mandel, Ilana, Paperna, Tamar, Glass‐Marmor, Lea, Volkowich, Anat, Badarny, Samih, Schwartz, Ilya, Vardi, Pnina, Koren, Ilana, Miller, Ariel · 2012 · Journal of Cellular and Molecular Medicine
Cited by 64

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

The tight junction proteins (TJPs) are major determinants of endothelial cells comprising physiological vascular barriers such as the blood–brain barrier, but little is known about their expression and role in immune cells. In this study we assessed TJP expression in human leukocyte subsets, their induction by immune activation and modulation associated with autoimmune disease states and therapies. A consistent expression of TJP complexes was detected in peripheral blood leukocytes (PBLs), predominantly in B and T lymphocytes and monocytes, whereas the in vitro application of various immune cell activators led to an increase of claudin 1 levels, yet not of claudin 5. Claudins 1 and 5 levels were elevated in PBLs of multiple sclerosis (MS) patients in relapse, relative to patients in remission, healthy controls and patients with other neurological disorders. Interestingly, claudin 1 protein levels were elevated also in PBLs of patients with type 1 diabetes (T1D). Following glucocorticoid treatment of MS patients in relapse, RNA levels of JAM3 and CLDN5 and claudin 5 protein levels in PBLs decreased. Furthermore, a correlation between CLDN5 pre‐treatment levels and clinical response phenotype to interferon‐β therapy was detected. Our findings indicate that higher levels of leukocyte claudins are associated with immune activation and specifically, increased levels of claudin 5 are associated with MS disease activity. This study highlights a potential role of leukocyte TJPs in physiological states, and autoimmunity and suggests they should be further evaluated as biomarkers for aberrant immune activity and response to therapy in immune‐mediated diseases such as MS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2011.01380.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 64

Metadata

Authors
Mandel, I., Paperna, T., Glass‐Marmor, L., Volkowich, A., Badarny, S., Schwartz, I., Vardi, P., Koren, I., & Miller, A.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2012-04
Volume
16
Issue
4
Pages
765-775
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W2005389806
Cited by
64
References
11
FWCI
1.68
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tight junction proteins expression and modulation in immune cells and multiple sclerosis. https://app.cochat.ai/papers/10.1111/j.1582-4934.2011.01380.x
The paper
Mandel, I., Paperna, T., Glass‐Marmor, L., Volkowich, A., Badarny, S., Schwartz, I., Vardi, P., Koren, I., & Miller, A. (2012). Tight junction proteins expression and modulation in immune cells and multiple sclerosis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2011.01380.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.